companies / inquismedical-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-05 json
| total_raised | 40,000,00040.0M | ○ |
|---|---|---|
| founded | null | |
| hq | Menlo Park CA | |
| industry | unknown | |
| stage | series-b+ |
Inquis Medical makes the AVENTUS thrombectomy system, a catheter that removes clots while returning the patient's blood. It serves physicians treating pulmonary embolism and venous thromboembolism. Its TrueClot sensing detects tissue in real time, and the system received FDA clearance in 2025.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2024-11-01 | series-b | 40,000,00040.0M | null | ○ |
Cloudflare, WordPress, Astra 4.13.1, Yoast SEO 27.6, UIKit, Google Analytics, Google Tag Manager, Site Kit 1.179.0, jQuery Migrate 3.4.1, imagesLoaded 5.0.0, Elementor 4.0.8, DoubleClick Floodlight
| fact | status | src |
|---|---|---|
| Series B, $40.0M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |